Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.
Weisi Yan presented his work on immunology-driven radiation oncology at the International Conference on Advances in Radiation Oncology in Vienna, Austria.
The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.
Physicians and scientists from the UK Markey Cancer Center will share their latest research at the American Society of Clinical Oncology’s annual meeting in Chicago from May 30 to June 3.
UK Markey Cancer Center researchers have identified a mechanism by which a gut hormone contributes to fatty liver disease, offering potential new targets for treating the common condition.
The UK Markey Cancer Center has enrolled its 10,000th patient in the Oncology Research Information Exchange Network (ORIEN) since joining the alliance in 2017.
At the annual gathering of cancer experts, the UK Markey Cancer Center team will present studies with the potential to significantly transform cancer care.
